polvitolimod   Click here for help

GtoPdb Ligand ID: 11872

Synonyms: compound 32 [WO2019226977A1] [1]
Compound class: Synthetic organic
Comment: Polvitolimod is classified as a toll-like receptor agonist in WHO proposed INN list 126 (January 2022). It was included in the 'COVID' section of that list. Patent mining suggests that polvitolimod is a TLR7 agonist prodrug, that was developed by Primmune Therapeutics as a potential treatment of cancer and infectious disease. In patent WO2019226977 polvitolimod's chemical structure matches that of Compound 32 [1]. Assessment of Primmune Therapeutics' pipeline indicates that polvitolimod is likely to be their clinical candidate PRTX007. If this is the correct name-to-structure association the active drug (PRX034) is likely to be compound 27 as claimed in the patent.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 3
Topological polar surface area 128.42
Molecular weight 323.1
XLogP -1.71
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES C#CCn1c(=O)n(c2c1cnc(n2)N)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO
Isomeric SMILES Nc1ncc2n(c(=O)n(c2n1)[C@H]1[C@H](O)[C@@H]([C@H](O1)CO)F)CC#C
InChI InChI=1S/C13H14FN5O4/c1-2-3-18-6-4-16-12(15)17-10(6)19(13(18)22)11-9(21)8(14)7(5-20)23-11/h1,4,7-9,11,20-21H,3,5H2,(H2,15,16,17)/t7-,8-,9-,11-/m1/s1
InChI Key NPRYCHLHHVWLQZ-TURQNECASA-N
Classification Click here for help
Compound class Synthetic organic
Is prodrug? Yes
Active form compound 27 [WO2019226977A1]
IUPAC Name Click here for help
2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one
International Nonproprietary Names Click here for help
INN number INN
12239 polvitolimod
Synonyms Click here for help
compound 32 [WO2019226977A1] [1]
Database Links Click here for help
CAS Registry No. 2389988-81-0 (source: WHO INN record)
GtoPdb PubChem SID 461663428
PubChem CID 151237987
Search Google for chemical match using the InChIKey NPRYCHLHHVWLQZ-TURQNECASA-N
Search Google for chemicals with the same backbone NPRYCHLHHVWLQZ
Search PubMed clinical trials polvitolimod
Search PubMed titles polvitolimod
Search PubMed titles/abstracts polvitolimod
UniChem Compound Search for chemical match using the InChIKey NPRYCHLHHVWLQZ-TURQNECASA-N
UniChem Connectivity Search for chemical match using the InChIKey NPRYCHLHHVWLQZ-TURQNECASA-N